- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Type 1 diabetes mellitus
- Meeting Date: July 2025
- Public Summary Document (PSD) July 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) July 2025 PBAC Meeting - (Word)
Insulin degludec – July 2025
Insulin degludec; Solution for injection 100 units per mL; Tresiba® Penfill®
Last updated
9 July 2025